Retrieve available abstracts of 11 articles: HTML format
Single Articles
August 2025
ROKKAS T, Ekmektzoglou K, Tsanou E, Bricca L, et al Comparative effectiveness and safety of probiotics with psychotropic potential in
mental health benefits in irritable bowel syndrome: a systematic review and
network meta-analysis.
Eur J Gastroenterol Hepatol. 2025 Aug 25. doi: 10.1097/MEG.0000000000003062. PubMedAbstract available
April 2025
ARIF TB, Ali SH, Bhojwani KD, Sadiq M, et al Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024
using the Rome III and IV criteria: a meta-analysis.
Eur J Gastroenterol Hepatol. 2025 Apr 30. doi: 10.1097/MEG.0000000000002994. PubMedAbstract available
August 2024
LIPTAK P, Duricek M, Schnierer M, Ziacikova IL, et al Symptoms of functional dyspepsia and irritable bowel syndrome among medical
students in Slovakia and their relation to diet and exercise.
Eur J Gastroenterol Hepatol. 2024;36:985-992. PubMedAbstract available
July 2024
LIU T, Wang Z, Kang X, Wang X, et al Causal relationships between psychological disorders and functional
gastrointestinal disorders: a bidirectional two-sample Mendelian randomization
study.
Eur J Gastroenterol Hepatol. 2024 Jul 8. doi: 10.1097/MEG.0000000000002825. PubMedAbstract available
November 2023
WANG YN, Zhou LY, Huang YH, Jiang M, et al The incidence and predisposing factors for irritable bowel syndrome following
COVID-19: a systematic review and meta-analysis.
Eur J Gastroenterol Hepatol. 2023 Nov 30. doi: 10.1097/MEG.0000000000002688. PubMedAbstract available
April 2023
YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al Exercise habits that include exercise partners and irritable bowel syndrome in a
young Japanese population: a cross-sectional study.
Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002561. PubMedAbstract available
January 2023
ROKKAS T, Hold GL A systematic review, pairwise meta-analysis and network meta-analysis of
randomized controlled trials exploring the role of fecal microbiota
transplantation in irritable bowel syndrome.
Eur J Gastroenterol Hepatol. 2023 Jan 31. doi: 10.1097/MEG.0000000000002519. PubMedAbstract available
SIYAL M, Abbas Z, Ashraf J, Ali Qadeer M, et al Incidence and predisposing factors for de novo post-COVID-19 irritable bowel
syndrome.
Eur J Gastroenterol Hepatol. 2023;35:59-63. PubMedAbstract available
September 2022
CHENG F, Fan Z, Lin C, Zhu Y, et al Effect of altered gut microbiota on visceral hypersensitivity of postinfectious
irritable bowel syndrome mice.
Eur J Gastroenterol Hepatol. 2022 Sep 12. pii: 00042737-990000000-00069. PubMedAbstract available
March 2022
HASSANIN TM, Fouad Y, Mohamed FE, Abdel-Hafeez EH, et al Colonic mucosal eosinophilia and immunohistochemical expression of COX-2 and
NF-kB in patients with irritable bowel syndrome.
Eur J Gastroenterol Hepatol. 2022 Mar 10. pii: 00042737-900000000-97082. PubMedAbstract available
February 2022
HURYCH J, Vodolanova L, Vejmelka J, Drevinek P, et al Freezing of faeces dramatically decreases the viability of Blastocystis sp. and
Dientamoeba fragilis.
Eur J Gastroenterol Hepatol. 2022;34:242-243. PubMed